Hospital
ST. John Broken Arrow, INC
ST. John Broken Arrow, INC was paid $2.22M by Medicaid between Jan 2018 and Nov 2024, across 34 billing codes. Its largest line is 99283, emergency room visit (moderate) — 59% of everything it billed.
33Billing provider infoST. JOHN BROKEN ARROW, INC
BROKEN ARROW, OK 74012
BROKEN ARROW, OK 74012
33aNPI1497988596assigned 08/24/2009
33bProvider typeGeneral Acute Care Hospital
28Total paid$2.22M
24GClaims26,520
24DCodes billed34
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other General Acute Care Hospital providers in Oklahoma
Rank by total paid#47 of 75
Median peer was paid$3.66M
This provider vs. median0.6×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 3,202 | $285K | |
| 2019 | 1,876 | $175K | |
| 2020 | 1,046 | $97K | |
| 2021 | 2,321 | $206K | |
| 2022 | 5,646 | $472K | |
| 2023 | 9,234 | $740K | |
| 2024incomplete | 3,195 | $245K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 59% | 7,671 | 7,634 | $1.31M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 14% | 1,124 | 1,120 | $310K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 9.4% | 1,411 | 1,396 | $208K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 5.4% | 347 | 342 | $121K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 4.3% | 926 | 923 | $96K |
| 80053 | Comprehensive metabolic panel | 2.8% | 4,346 | 4,302 | $63K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.5% | 5,078 | 5,019 | $33K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.1% | 1,694 | 849 | $23K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 442 | 427 | $14K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 280 | 280 | $13K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 49 | 49 | $9K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 512 | 508 | $8K |
22 more codes
| 81025 | <1% | 405 | $3K | |
| 83690 | <1% | 296 | $2K | |
| 71045 | Radiologic examination, chest; single view | <1% | 82 | $1K |
| 81001 | <1% | 357 | $937.82 | |
| 83605 | <1% | 88 | $884.94 | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 26 | $783.34 |
| 81003 | <1% | 245 | $655.09 | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 12 | $607.97 |
| 36415 | Collection of venous blood by venipuncture | <1% | 135 | $543.34 |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 75 | $386.97 |
| 87807 | <1% | 25 | $287.79 | |
| 84484 | <1% | 26 | $273.25 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 153 | $203.88 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 253 | $110.76 |
| J7120 | Ringers lactate infusion, up to 1000 cc | 0% | 39 | $0.00 |
| J7030 | Infusion, normal saline solution , 1000 cc | 0% | 46 | $0.00 |
| A4565 | Slings | 0% | 15 | $0.00 |
| J0690 | Injection, cefazolin sodium, 500 mg | 0% | 95 | $0.00 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 0% | 108 | $0.00 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 0% | 44 | $0.00 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 0% | 63 | $0.00 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 0% | 52 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialADAMS, MATT (CEO)
Parent organizationST. JOHN HEALTH SYSTEM, INC.
| Provider | Location | Paid |
|---|---|---|
| Peaster Independent School District | Weatherford, TX | $85K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.